Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial.
Author
NOEL-BARON, F
Özgüroglu, Mustafa
FAN, J
LOUVEAU, AL
BURRIS, H
JERUSALEM, G
de, Boer
HURVITZ, S
YARDLEY, DA
KOVALENKO, E
EJLERTSEN, B
BLAU, S
LANDHERR, L
EWERTZ, M
TARAN, T
Metadata
Show full item recordCollections
- Makale [92796]